The main purposes of current study were: first, transdiagnostic group therapy was used for indicated prevention of subclinical anxiety and depressive symptoms and second, transdiagnostic group therapy was compared with group cognitive therapy as a gold standard treatment for anxiety and depression. Participants were selected from college students that had subclinical anxiety and depressive symptoms. They were randomly assigned into two groups. 33 students were participated in 8 weekly sessions. Among participants, 16 persons belong to control group (group cognitive therapy) and 17 persons belong to experimental group (transdiagnostic group therapy). Self-report measures were completed pre-intervention, post-intervention and 3 months post-intervention. Primary evaluation showed that experimental group is more efficacious than cognitive group therapy in reducing anxiety symptoms and improving emotion regulation.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT138903244178N1
Registration date:2011-11-28, 1390/09/07
Registration timing:retrospective
Last update:
Update count:0
Registration date
2011-11-28, 1390/09/07
Registrant information
Name
Abolfazl Mohammadi
Name of organization / entity
Tehran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 5541 9151
Email address
amohammadi@stu.iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Tehran University of Medical Sciences
Expected recruitment start date
2011-01-21, 1389/11/01
Expected recruitment end date
2011-03-21, 1390/01/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the Transdiagnostic Group Therapy with Group Cognitive Therapy on Indicated Prevention of Anxiety and Depression
Public title
Indicated Prevention of Anxiety and Depression
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria: anxiety and depression symptoms based on the cut-off of 18 and higher in the depression subscale and score of 16 and higher in the anxiety subscale of The Depression, Anxiety, and Stress Scale (DASS-42; Lovibond & Lovibond, 1993).
Exclusion criteria: Having axes I or II disorders; receiving psychotherapy or medication; having serious physical problems
Age
From 18 years old to 40 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
30
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Tehran University of Medical Sciences
Street address
Floor 6, TUMS Head Office, Keshavars, Blv. Tehran, Iran
City
Tehran
Postal code
Approval date
2011-08-01, 1390/05/10
Ethics committee reference number
709/130/د/90
Health conditions studied
1
Description of health condition studied
Anxiety and Depressive symptoms
ICD-10 code
F41.9
ICD-10 code description
Anxiety disorder, unspecified
Primary outcomes
1
Description
Depressive symptoms
Timepoint
pre, post and after 3 maonth follow up
Method of measurement
self report
Secondary outcomes
1
Description
anxiety symptoms
Timepoint
pre, post and after 3 month follow-up
Method of measurement
self report questionaire
Intervention groups
1
Description
Experimental group was participated in transdiagnostic group therapy at 8 weeks for 2 hours. Therapeutic components of transdiagnostic group therapy were including: emotional awareness training, cognitive appraisal and reappraisal, countering emotion driven behaviors and emotional avoidance.
Category
Prevention
2
Description
Cognitive group therapy as an treatment as usual was used for control group at 8sessons. Basic techniques of cognitive therapy such as cognitive restructuring and down ward arrow were used in control group.
Category
Prevention
Recruitment centers
1
Recruitment center
Name of recruitment center
Universities in Tehran
Full name of responsible person
Street address
City
Tehran
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Abolfazl Mohammadi
Street address
No 1, Tehran Psyciatric Institute, Niayesh Sattarkhan, Tehran, Iran
City
Tehran
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty
Person responsible for general inquiries
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Abolfazl Mohammadi
Position
Doctoral Candidate in clinical psychology
Other areas of specialty/work
Street address
No 1, Tehran Psychiatric Institute, Mansouri Str., Niayesh Str. Sattarkhan, Tehran Iran
City
Tehran
Postal code
Phone
+98 21 4426 2817
Fax
Email
amohammadee@gmail.com
Web page address
www.acpsy.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Abolfazl Mohammadi
Position
Doctoral candidate in clinical psyhology
Other areas of specialty/work
Street address
No 1, Tehran Psychiatric Institute, Mansouri Str., Niayesh Str. Sattarkhan, Tehran Iran
City
Tehran
Postal code
Phone
+98 21 4426 4817
Fax
Email
amohammadee@gmail.com
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Abolfazl Mohammadi
Position
Doctoral Candidate in Clinical Psychology
Other areas of specialty/work
Street address
No 1, Tehran Psychiatric Institute, Mansouri Str., Niayesh Str. Sattarkhan, Tehran Iran
City
Tehran
Postal code
Phone
+98 21 4426 4817
Fax
Email
amohammadee@gmail.com
Web page address
www.acpsy.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)